PROTECTIVE ACTION OF AMIODARONE AGAINST VENTRICULAR-FIBRILLATION IN THE ISOLATED PERFUSED RAT-HEART

被引:60
作者
LUBBE, WF
MCFADYEN, ML
MULLER, CA
WORTHINGTON, M
OPIE, LH
机构
[1] UNIV CAPE TOWN,DEPT MED,MRC,ISCHEM HEART DIS RES UNIT,CAPE TOWN 7900,SOUTH AFRICA
[2] GROOTE SCHUUR HOSP,CAPE TOWN,SOUTH AFRICA
基金
英国医学研究理事会;
关键词
D O I
10.1016/0002-9149(79)90010-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The pretreatment of rats with amiodarone for 2 minutes to 3 weeks before the excision of their hearts caused a dose-related decrease in heart rate and an increase in the ventricular fibrillation threshold both before and after coronary arterial ligation. Similarly, amiodarone decreased the incidence of ventricular premature extrasystoles, ventricular tachycardia and fibrillation during the period of regional ischemia after coronary arterial ligation and also after reperfusion of the ischémie myocardium. There was no evidence of a metabolic protective effect on ischemic myocardium because tissue high energy phosphate content decreased to a similar extent in ischemic myocardium from control and amiodarone-treated rats. Instead, the protective effect of amiodarone against fibrillation was accompanied by attenuation of the increase in tissue cyclic adenosine monophosphate in ischemic myocardium after coronary arterial ligation. It is proposed that amiodarone exerts a potent antifibrillatory effect by decreasing tissue cyclic adenosine monophosphate in ischemic myocardium. © 1979.
引用
收藏
页码:533 / 540
页数:8
相关论文
共 21 条
[1]  
CHARLIER R, 1968, ARZNEI-FORSCHUNG, V18, P1408
[2]   DIFFERING MECHANISMS FOR VENTRICULAR VULNERABILITY DURING CORONARY-ARTERY OCCLUSION AND RELEASE [J].
CORBALAN, R ;
VERRIER, RL ;
LOWN, B .
AMERICAN HEART JOURNAL, 1976, 92 (02) :223-230
[3]   MECHANISMS OF ACTIVATION OF CARDIAC GLYCOGEN-PHOSPHORYLASE IN ISCHEMIA AND ANOXIA [J].
DOBSON, JG ;
MAYER, SE .
CIRCULATION RESEARCH, 1973, 33 (04) :412-420
[4]   QUALITY OF IDEAL ANTIARRHYTHMIC DRUG [J].
DREIFUS, LS ;
OGAWA, S .
AMERICAN JOURNAL OF CARDIOLOGY, 1977, 39 (03) :466-468
[5]   EXPERIMENTAL MYOCARDIAL-INFARCTION WITH LEFT-VENTRICULAR FAILURE IN ISOLATED PERFUSED RAT-HEART - EFFECTS OF ISOPROTERENOL AND PACING [J].
KANNENGIESSER, GJ ;
LUBBE, WF ;
OPIE, LH .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1975, 7 (02) :135-151
[6]   VENTRICULAR ARRHYTHMIAS ASSOCIATED WITH CORONARY-ARTERY OCCLUSION AND REPERFUSION IN ISOLATED PERFUSED RAT-HEART - MODEL FOR ASSESSMENT OF ANTIFIBRILLATORY ACTION OF ANTIARRHYTHMIC AGENTS [J].
LUBBE, WF ;
DARIES, PS ;
OPIE, LH .
CARDIOVASCULAR RESEARCH, 1978, 12 (04) :212-220
[7]   VENTRICULAR-FIBRILLATION THRESHOLD AND VULNERABLE PERIOD IN ISOLATED PERFUSED RAT-HEART [J].
LUBBE, WF ;
BRICKNELL, OL ;
MARZAGAO, C .
CARDIOVASCULAR RESEARCH, 1975, 9 (05) :613-620
[8]   ROLE OF CYCLIC ADENOSINE-MONOPHOSPHATE IN REGULATION OF VULNERABILITY TO VENTRICULAR-FIBRILLATION IN RAT-HEART [J].
LUBBE, WF ;
OPIE, LH .
AMERICAN JOURNAL OF CARDIOLOGY, 1978, 41 (02) :417-417
[9]   ROLE OF CYCLIC ADENOSINE-MONOPHOSPHATE IN ADRENERGIC EFFECTS ON VENTRICULAR VULNERABILITY TO FIBRILLATION IN ISOLATED PERFUSED RAT-HEART [J].
LUBBE, WF ;
PODZUWEIT, T ;
DARIES, PS ;
OPIE, LH .
JOURNAL OF CLINICAL INVESTIGATION, 1978, 61 (05) :1260-1269
[10]  
PODZUWEIT T, 1976, LANCET, V1, P341